M
Mike Recher
Researcher at University of Zurich
Publications - 27
Citations - 1768
Mike Recher is an academic researcher from University of Zurich. The author has contributed to research in topics: Virus & T cell. The author has an hindex of 16, co-authored 27 publications receiving 1679 citations. Previous affiliations of Mike Recher include Beth Israel Deaconess Medical Center.
Papers
More filters
Journal ArticleDOI
Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease.
Karl S. Lang,Mike Recher,Tobias Junt,Alexander A. Navarini,Nicola L. Harris,Stefan Freigang,Bernhard Odermatt,Curdin Conrad,Lars M. Ittner,Stefan Bauer,Sanjiv A. Luther,Satoshi Uematsu,Shizuo Akira,Hans Hengartner,Rolf M. Zinkernagel +14 more
TL;DR: The circumstances under which CD8+ T cells specific for pancreatic beta-islet antigens induce disease in mice expressing lymphocytic choriomeningitis virus as a transgene under the control of the rat insulin promoter are investigated to identify the 'inflammatory status' of the target organ as a separate and limiting factor determining the development of autoimmune disease.
Journal ArticleDOI
Aggravation of viral hepatitis by platelet-derived serotonin
Philipp A. Lang,Claudio Contaldo,Panco Georgiev,Ashraf Mohammad El-Badry,Mike Recher,Michael O. Kurrer,Luisa Cervantes-Barragan,Burkhard Ludewig,Thomas Calzascia,Beatrice Bolinger,Doron Merkler,Doron Merkler,Bernhard Odermatt,Michael Bader,Rolf Graf,Pierre-Alain Clavien,Ahmed N. Hegazy,Ahmed N. Hegazy,Max Löhning,Max Löhning,Nicola L. Harris,Pamela S. Ohashi,Hans Hengartner,Rolf M. Zinkernagel,Karl S. Lang,Karl S. Lang +25 more
TL;DR: Serotonin treatment of infected mice delayed entry of activated CD8+ T cells into the liver, delayed virus control and aggravated immunopathological hepatitis, suggesting vasoactive serotonin supports virus persistence in the liver and aggravates virus-induced immunopathology.
Journal ArticleDOI
Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections.
Lukas Hunziker,Lukas Hunziker,Mike Recher,Andrew J. Macpherson,Adrian Ciurea,Stefan Freigang,Hans Hengartner,Rolf M. Zinkernagel +7 more
TL;DR: Hypergammaglobulinemia may arise when specific helper T cells recognize B cells that have processed viral antigens irrespective of the B cell receptor specificity, and this nonspecific B cell activation may contribute to antibody-mediated autoimmunity.
Journal ArticleDOI
Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling
Karl S. Lang,Panco Georgiev,Mike Recher,Alexander A. Navarini,Andreas Bergthaler,Mathias Heikenwalder,Nicola L. Harris,Tobias Junt,Tobias Junt,Bernhard Odermatt,Pierre-Alain Clavien,Hanspeter Pircher,Shizuo Akira,Hans Hengartner,Rolf M. Zinkernagel +14 more
TL;DR: It is demonstrated that highly activated liver-specific effector CD8+ T cells alone were not sufficient to trigger immune destruction of the liver in mice, and only additional innate immune signals orchestrated by TLR3 provoked liver damage.
Journal ArticleDOI
Deliberate removal of T cell help improves virus-neutralizing antibody production
Mike Recher,Karl S. Lang,Lukas Hunziker,Lukas Hunziker,Stefan Freigang,Bruno Eschli,Nicola L. Harris,Alexander A. Navarini,Beatrice M. Senn,Katja Fink,Marius Lötscher,Lars Hangartner,Raphaël M. Zellweger,Martin Hersberger,Alexandre Theocharides,Hans Hengartner,Rolf M. Zinkernagel +16 more
TL;DR: Evidence is provided that, paradoxically, because of polyclonal B cell activation, virus-specific T cell help impairs the induction of neutralizing antibody responses.